The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
CORONARY INTERVENTIONS
Long-term follow-up of second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction: three-year results of the XAMI trial
EuroIntervention 2015;10:1280-1283 published online ahead of print January 2015. DOI: 10.4244/EIJY15M01_03
Sjoerd H. Hofma1*, MD, PhD; Pieter C. Smits2, MD, PhD; Jan Brouwer1, MD, PhD; Matthijs A. Velders1, MD, PhD; Arnoud W.J. van ’t Hof3, MD, PhD; Michel Queré1, MD; Cornelis Jan de Vries1, MD; Adrianus J. van Boven1, MD, PhD
1. Medical Center Leeuwarden, Leeuwarden, The Netherlands; 2. Maasstad Hospital Rotterdam, Rotterdam, The Netherlands; 3. Isala Clinics, Zwolle, The Netherlands
Aims: Evaluation of the long-term safety and efficacy of second-generation everolimus-eluting stents (EES) versus first-generation sirolimus-eluting stents (SES) in acute myocardial infar